Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 11,198 shares at $8.75 ($97K) on 2018-11-20, disclosed to the SEC on 2018-11-21.
Open-market sale of $97k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.30 | 75 | $623 | 0.6% |
| 2 | $8.57 | 4,623 | $40K | 40.8% |
| 3 | $8.75 | 6,500 | $57K | 58.6% |
| Total | $8.67 avg | 11,198 | $97K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-05-06 | $126K | — | Filing → |